PALO ALTO, Calif., Oct. 23, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that its management will hold a fiscal year 2013 review for investors on November 5, 2013 at the Marriott Marquis, 1535 Broadway, New York, from 11:30 a.m. ET to 1:00 p.m. ET.
Management will include Dow Wilson, CEO; Dow Wilson, Kolleen Kennedy, Senior Vice President and President of Oncology Systems; Elisha Finney, Executive Vice President and CFO; and Spencer Sias, Vice President, Investor Relations.
You may RSVP by contacting Anne Rambo at (650) 424-5834, or email: email@example.com.
The meeting will be webcast and may be accessed via: www.varian.com/pt-br/pt-br/investor
Web conferences will be archived on the company website for a year. Additional information about Varian Medical Systems can be obtained on the company's website. Investors can subscribe to receive automatic "e-mail alerts" regarding Varian news and events via the company website at www.varian.com/pt-br/pt-br/investor.
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,350 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.
FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
Vice President, Corporate Communications
and Investor Relations
SOURCE Varian Medical Systems